Cardio-oncology is a fast-evolving discipline focused on preventing, detecting, and managing cardiovascular complications in people living with and beyond cancer. Cancer survivors face a significantly higher burden of cardiovascular disease due to the cardiotoxic effects of cancer treatments as well as shared risk factors. As cancer survival rates continue to grow, cardiovascular health is increasingly central to long-term patient outcomes, requiring integrated care that optimizes both cancer treatment success and lifelong heart health.

The Inaugural ACORES Meeting successfully built a powerful, multidisciplinary network connecting cardiology, oncology, hematology, radiation oncology, pharmacy, and allied health professionals across Australia.

Across two comprehensive days, the March 2026 symposium featured national and international experts who led critical discussions, presented cutting-edge research, and shared best-practice clinical insights—marking a pivotal moment in the development of Australia’s cardio-oncology community.

​

The event successfully brought together leading minds across multiple fields, including:

• Medical Specialists: Consultant and trainee cardiologists, medical and radiation oncologists, and hematologists.

• Allied Health Professionals: Dedicated nurses, technicians, cancer care coordinators, exercise physiologists, physiotherapists, and dietitians involved in the continuum of cancer care.

• Scientific Pioneers: Fundamental, translational, and clinical researchers driving innovation in cardio-oncology.

​

This landmark inaugural event would not have been possible without the vision, leadership, and dedication of our esteemed Steering Committee:

​​

Dr Daniel Chen,  Prof Doan Ngo,  Prof Aaron Sverdlov,   Dr Sanjeev Kumar,   Dr Satish Ramkumar,   Dr Mark Nolan,   Prof Constantine Tam,   Prof Jarad Martin,   Dr Phillipa Ell